Answers are grounded in this paper and cite their sources.
In Algeria, the incidence of colorectal cancer has risen alarmingly, ranking it as the second most common cancer. Our study focused on 93 individuals with metastatic colorectal cancer diagnosed at the CHU of Bejaia between January 2018 and April 2022. Our aim was to describe the clinical and molecular profiles of these patients, as well as associated risk factors.The results of the epidemiological study show a steady increase in the incidence of metastatic colorectal cancer, a male predominance (sex ratio of 2.7) and an average age of 63 years. Most patients had few known risk factors for colorectal cancer.Clinical symptoms were dominated by rectal discharge, abdominal pain, iron-deficiency anemia, and transit disorders. Nine patients underwent emergency surgery for intestinal obstruction.Anatomopathological study revealed a predominance of liberkühnian adenocarcinomas, mainly well-differentiated. The most frequent primary location was the left colon. Metastases were most frequently found in the liver (63% of cases).Molecular analysis revealed mutations in at least one gene involved in colorectal cancer in 62.4% of patients. The most frequent mutation was in RAS, present in 37.6% of cases.
No takes yet. Share an insight, caveat, or question.
Mazouzi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: